Your browser doesn't support javascript.
loading
Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
Tauziède-Espariat, Arnault; Siegfried, Aurore; Nicaise, Yvan; Kergrohen, Thomas; Sievers, Philipp; Vasiljevic, Alexandre; Roux, Alexandre; Dezamis, Edouard; Benevello, Chiara; Machet, Marie-Christine; Michalak, Sophie; Puiseux, Chloe; Llamas-Gutierrez, Francisco; Leblond, Pierre; Bourdeaut, Franck; Grill, Jacques; Dufour, Christelle; Guerrini-Rousseau, Léa; Abbou, Samuel; Dangouloff-Ros, Volodia; Boddaert, Nathalie; Saffroy, Raphaël; Hasty, Lauren; Wahler, Ellen; Pagès, Mélanie; Andreiuolo, Felipe; Lechapt, Emmanuèle; Chrétien, Fabrice; Blauwblomme, Thomas; Beccaria, Kévin; Pallud, Johan; Puget, Stéphanie; Uro-Coste, Emmanuelle; Varlet, Pascale.
Afiliación
  • Tauziède-Espariat A; Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France. a.tauziede-espariat@ghu-paris.fr.
  • Siegfried A; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR S1266, INSERM, IMA-BRAIN, Paris, France. a.tauziede-espariat@ghu-paris.fr.
  • Nicaise Y; Université de Paris, Paris, France. a.tauziede-espariat@ghu-paris.fr.
  • Kergrohen T; Department of Pathology, Toulouse University Hospital, Toulouse, France.
  • Sievers P; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
  • Vasiljevic A; Université Paul Sabatier, Toulouse III, Toulouse, France.
  • Roux A; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
  • Dezamis E; Université Paul Sabatier, Toulouse III, Toulouse, France.
  • Benevello C; U981, Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
  • Machet MC; Department of Child and Adolescent Oncology, Gustave Roussy, Villejuif, France.
  • Michalak S; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Puiseux C; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center DKFZ, Heidelberg, Germany.
  • Llamas-Gutierrez F; Department of Pathology and Neuropathology, GHE, Hospices Civils de Lyon, Lyon, France.
  • Leblond P; Université de Paris, Paris, France.
  • Bourdeaut F; Department of Neurosurgery, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France.
  • Grill J; Department of Neurosurgery, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France.
  • Dufour C; Department of Neurosurgery, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France.
  • Guerrini-Rousseau L; Department of Pathology, Tours Hospital, Tours, France.
  • Abbou S; Department of Pathology, Angers Hospital, Angers, France.
  • Dangouloff-Ros V; Department of Oncology, Pontchaillou Hospital, Rennes, France.
  • Boddaert N; Department of Oncology, Pontchaillou Hospital, Rennes, France.
  • Saffroy R; Institute of Pediatric Hematology and Oncology (IHOPe), Centre Léon Bérard, Lyon, France.
  • Hasty L; Department of Pediatric Oncology, Institut Curie, Paris, France.
  • Wahler E; Department of Child and Adolescent Oncology, Gustave Roussy, Villejuif, France.
  • Pagès M; Gustave Roussy Cancer Center and Paris-Saclay University, «Genomics and Oncogenesis of Pediatric Brain Tumors¼ INSERM U981, Villejuif, France.
  • Andreiuolo F; Department of Child and Adolescent Oncology, Gustave Roussy, Villejuif, France.
  • Lechapt E; Gustave Roussy Cancer Center and Paris-Saclay University, «Genomics and Oncogenesis of Pediatric Brain Tumors¼ INSERM U981, Villejuif, France.
  • Chrétien F; Department of Child and Adolescent Oncology, Gustave Roussy, Villejuif, France.
  • Blauwblomme T; Gustave Roussy Cancer Center and Paris-Saclay University, «Genomics and Oncogenesis of Pediatric Brain Tumors¼ INSERM U981, Villejuif, France.
  • Beccaria K; Department of Child and Adolescent Oncology, Gustave Roussy, Villejuif, France.
  • Pallud J; Université de Paris, Paris, France.
  • Puget S; Pediatric Radiology Department, AP-HP, Hôpital Universitaire Necker-Enfants Malades, 75015, Paris, France.
  • Uro-Coste E; Université de Paris, INSERM ERL UA10, INSERM U1163, Institut Imagine, 75015, Paris, France.
  • Varlet P; Université de Paris, Paris, France.
Acta Neuropathol Commun ; 9(1): 135, 2021 08 13.
Article en En | MEDLINE | ID: mdl-34389065
ABSTRACT
The cIMPACT-NOW Update 7 has replaced the WHO nosology of "ependymoma, RELA fusion positive" by "Supratentorial-ependymoma, C11orf95-fusion positive". This modification reinforces the idea that supratentorial-ependymomas exhibiting fusion that implicates the C11orf95 (now called ZFTA) gene with or without the RELA gene, represent the same histomolecular entity. A hot off the press molecular study has identified distinct clusters of the DNA methylation class of ZFTA fusion-positive tumors. Interestingly, clusters 2 and 4 comprised tumors of different morphologies, with various ZFTA fusions without involvement of RELA. In this paper, we present a detailed series of thirteen cases of non-RELA ZFTA-fused supratentorial tumors with extensive clinical, radiological, histopathological, immunohistochemical, genetic and epigenetic (DNA methylation profiling) characterization. Contrary to the age of onset and MRI aspects similar to RELA fusion-positive EPN, we noted significant histopathological heterogeneity (pleomorphic xanthoastrocytoma-like, astroblastoma-like, ependymoma-like, and even sarcoma-like patterns) in this cohort. Immunophenotypically, these NFκB immunonegative tumors expressed GFAP variably, but EMA constantly and L1CAM frequently. Different gene partners were fused with ZFTA NCOA1/2, MAML2 and for the first time MN1. These tumors had epigenetic homologies within the DNA methylation class of ependymomas-RELA and were classified as satellite clusters 2 and 4. Cluster 2 (n = 9) corresponded to tumors with classic ependymal histological features (n = 4) but also had astroblastic features (n = 5). Various types of ZFTA fusions were associated with cluster 2, but as in the original report, ZFTAMAML2 fusion was frequent. Cluster 4 was enriched with sarcoma-like tumors. Moreover, we reported a novel anatomy of three ZFTANCOA1/2 fusions with only 1 ZFTA zinc finger domain in the putative fusion protein, whereas all previously reported non-RELA ZFTA fusions have 4 ZFTA zinc fingers. All three cases presented a sarcoma-like morphology. This genotype/phenotype association requires further studies for confirmation. Our series is the first to extensively characterize this new subset of supratentorial ZFTA-fused ependymomas and highlights the usefulness of ZFTA FISH analysis to confirm the existence of a rearrangement without RELA abnormality.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Supratentoriales / Proteínas / Ependimoma Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Acta Neuropathol Commun Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Supratentoriales / Proteínas / Ependimoma Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Acta Neuropathol Commun Año: 2021 Tipo del documento: Article País de afiliación: Francia